摘要
目的:探讨阿托伐他汀治疗血脂紊乱的疗效。方法:口服阿托伐他汀10mg,每日1次。患者在治疗期间进行标准的低胆固醇饮食维持合理的膳食。伴有高血压、冠心病或糖尿病患者继续服用不影响脂质代谢的药物。同时用药前后检测肝、肾功能、血浆肌酸激酶(CK)、血常规、心电图各一次。结果:治疗后观测指标的变化,用药4周末,患者血清TC,TG,LDL-C均有明显下降,与用药前比较差异有非常显著性(P<0.01);HDL-C则较治疗前明显上升(P<0.05)。本组显效21例,有效27例,无效2例,无恶化病例。结论:阿托伐他汀是TC合成的限速酶(HMG-COA还原酶)的抑制剂,可反馈性刺激细胞表面的LDL受体增加,加速LDL-C进入细胞降解,使血液中LDL-C水平降低。本文证实阿托伐他汀治疗高脂血症有效性高、安全、不良反应小,长期服用比较安全,患者耐受较好,是治疗高脂血症、血脂紊乱有效药物,值得临床推广应用。
Objective:The discussion atropic cuts down his sandbank treatment blood fats disorder the curative effect.Method:The oral administration atropic cuts down his sandbank 10mg,daily 1 time,patient in treatment period carries on the standard the low cholesterol diet maintenance reasonable meals.Is accompanied by hypertension,coronary disease or the diabetic continues to take does not affect the lipin metabolism the medicine.Around simultaneously applies drugs examines the liver,the kidney function,blood plasma creatine kinase (CK),the routine blood test, electrocardiogram each one time.Result:After the treatment,observes the target the change to apply drugs 4 weekends,patient blood serum TC,TG,LDL-C has the obvious drop,the comparison difference has the unusual significance before the medication(P〈0.05)HDk-C treats,the obvious rise(P〈0.05).This group shows results 21 examples,effective 27 examples,invalid 2 examples,non-worsened case.Concluslon:The atropic cuts down his sandbank is the TC synthesis regulating enzyme (the HMG-COA reductases) inhibitor, but the feedback irritation cell surface's LDL seceptor increases, accelerates LDL-C to enter the cell to degrade,causes in the blood the LDL-C level to reduce,This article confirmed that the atropic cuts down his sandbank to treat the hyperlipemia validity high, safe,the untoward effect to be small,takes the comparison security for a long time, the patient endures well,is treats the hyperlipemia,the blood fats disorder effective medicine,is worth the clinical promoted application.
出处
《中国医药导刊》
2009年第7期1151-1151,1239,共2页
Chinese Journal of Medicinal Guide
关键词
阿托伐他汀
血脂紊乱
治疗
Atorvastatin
Blood fats disorder
Treatment